Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
AssigneeUnited Biomedical, Inc.
InventorsAnna Efim Ladd, Chang Yi Wang, Timothy Joseph Zamb
Life of this patent
Estimating the term…
Loading patent…
AssigneeUnited Biomedical, Inc.
InventorsAnna Efim Ladd, Chang Yi Wang, Timothy Joseph Zamb
Estimating the term…
This invention relates to immunogenic luteinizing hormone releasing hormone (LHRH) peptides that lead to suppression of LHRH activity in males or females. These peptides are useful for inducing infertility and for treating prostatic hyperplasia, androgen-dependent carcinoma, prostatic carcinoma and testicular carcinoma in males. In females, the peptides are useful for treating endometriosis, benign uterine tumors, recurrent functional ovarian cysts and (severe) premenstrual syndrome as well as prevention or treatment of estrogen-dependent breast cancer. The subject peptides contain a helper T cell epitope and have LHRH at the C terminus. The helper T cell epitope aids in stimulating the immune response against LHRH. The peptides, optionally contain an invasin domain which acts as a general immune stimulator. In another aspect this invention relates to immunogenic synthetic peptides having an invasin domain, a helper T cell epitope and a peptide hapten and methods of using these peptides to treat disease or provide protective immunity. The peptide haptens of the invention include LHRH, amylin, gastrin, gastrin releasing peptide, IgE CH4 peptide, Chlamydia MOMP peptides, HIV V3 peptides and Plasmodium berghei.
A method for inducing infertility in a mammal which comprises administering to said mammal a composition comprising a peptide represented by the formula
A method for treatment of androgen dependent carcinoma which comprises administering a composition comprising a peptide represented by the formul a
A method for suppressing the activity of LHRH in a mammal which comprises administering a composition comprising a peptide represented by the formula
A method of suppressing LHRH activity in pigs, dogs, cats or stallions to reduce boar taint in male pigs, castrate cats or dogs or stallions by administering a composition comprising a peptide represented by the formul a
Dependencies are inferred from the claim text.